Company Profile

Biomedical Enterprises Inc (AKA: BME)
Profile last edited on: 1/17/20      CAGE: 1BNS4      UEI:

Business Identifier: Musculoskeletal research: orthopedic devices
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

14785 Omicron Drive Suite 205
San Antonio, TX 78245
   (210) 677-0354
Location: Single
Congr. District: 23
County: Bexar

Public Profile

Actively involved in SBIR when the firm was much younger, in May 2016, Biomedical Enterprises was acquired DePuy Orthopaedics, Inc., part of the DePuy Synthes Companies of Johnson & Johnson and is now functioning as a subsiduary, BioMedical Enterprises, Inc. (BME), had been a manufacturer of Nitinol orthopaedic implants for small bone fixation. The implants are used to treat bunions, hammertoes and other foot and ankle deformities, as well as hand and wrist deformities. The BME acquisition reinforces Johnson & Johnson Medical Devices focus on accelerating meaningful innovation and strengthening DePuy Synthes’ portfolio for elective extremity procedures - providing a more complete solution for foot and ankle and hand and wrist specialists. BME was among the first U.S. manufacturers of Nitinol metal implants for musculoskeletal fixation and is a market leader in the use of memory metal implants for bone fixation. Nitinol is a nickel-titanium alloy that provides dynamic continuous active compression, which helps to promote healing after bone fixation. BME implants come ready-to-use on a sterilized, pre-loaded, fully disposable insertion tool. BioMedical Enterprises, Inc. (BME) began as a privately held medical device company providing musculoskeletal research service to pharmaceutical, biotechnology, and orthopaedic industries working closely with leading teaching institutions and some of the world’s largest orthopaedic companies on various bone healing research projects. Over time BME entered the medical device market searching for products that would help bones heal faster and better. Through collaborations with a worldwide network of research and innovation, BME was introduced to memory metal compression bone staples and soon became the first to market heat-activated shape memory devices in the United States. Taking the concept one step further BME develop the ability to control the compressive forces these implants exert to make the system suitable for a variety of applications under varying degrees of bone qualities. The firm created and patented the OSSforceTM Implant Controller bringing all manufacturing activities in-house to ensure the best quality control possible while protecting intellectual property. BME evolved into a Reconstructive Bone Fusion product company with a comprehensive line of shape memory bone fusion implan

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1997 2 AF $634,840
Project Title: Oral Bone Implants Laser Sintered from Calcium Phosphate
1996 1 DARPA $98,956
Project Title: Aerospace Ceramics and Bone
1996 1 NIH $99,988
Project Title: 3D Calcium Carbonate Bone Replacement Material
1995 1 NIH $99,303
Project Title: Endosseous Implant for Delayed Immediate Placement
1995 1 NASA $69,981
Project Title: NASA Aerospace Ceramics And Bone

Key People / Management

  Todd Fanning

  William Casey Fox -- Founder, CEO and CTO

  Keith M Peeples -- President

  Nancy Fox

  William C Fox

  Eric A Marcano -- Marketing Manager,

  David Pancratz -- Vice President of Operations

  Lisa Parker -- Director, Finance & Administration

  Joe Soward -- Director of Quality Assurance,